Meeting
2024 ASCO Genitourinary Cancers Symposium
Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies.
Authors
Amy K Taylor
University of Wisconsin Hospital and Clinics, Madison, WI
Amy K Taylor , Kyle Helzer , Marina Nasrin Sharifi , Jamie M Sperger , Yue Shi , Matti Annala , Shannon Reese , Katherine Kaufmann , Jennifer L. Schehr , Nan Sethakorn , David Kosoff , Christos Kyriakopoulos , Andrew J. Armstrong , Rana R. McKay , Felix Y Feng , Kari Braun Wisinski , Hamid Emamekhoo , Alexander William Wyatt , Joshua Michael Lang , Shuang Zhao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 199)
DOI
10.1200/JCO.2024.42.4_suppl.199
Abstract #
199
Poster Bd #
J7
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic alterations in patients with prostate cancer with liver metastases.
First Author: Crystal Casado
Poster
2018 Genitourinary Cancers Symposium
Cell-free DNA (cfDNA) analysis and evaluation of BRAF amplifications and mutations in metastatic castration-resistant prostate cancer.
First Author: Peter Steinwald
Poster
2017 ASCO Annual Meeting
Whole exome sequencing (WES) of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer (NEPC) informs tumor heterogeneity.
First Author: Himisha Beltran
Poster
2017 Genitourinary Cancers Symposium
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
First Author: Werner J. Struss